“XP-23829, a Novel Fumaric Acid Ester, is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study”, J of Skin, vol. 1, no. 3.1, p. s33, Oct. 2017, doi: 10.25251/skin.1.supp.32.